SLC9A1 and breast cancer: Kaplan–Meier survival analysis shows that patients expressing high levels of both NHE1 and SWELL1 had lower DMFS (Fig. 6j (iii)), suggesting that inhibition of NHE1 and SWELL1 may represent a potential therapeutic regimen for suppressing breast cancer dissemination and metastasis in vivo.